AlphaTau announced in an official statement on October 29, 2026, that its common shares are scheduled to be included in the Tel Aviv Stock Exchange (TASE) TA-90 and TA-125 indices starting November 5. The TA-125 is the benchmark index of the Israeli stock market and includes companies from the TA-35 and TA-90.

The company expects this inclusion to expand its recognition among Israeli institutional investors, its local investor base, and trading liquidity. It also explained that inclusion of its shares in index-tracking funds is anticipated.

This announcement is distinct from news of a new listing. AlphaTau has already been dual-listed and traded on the NASDAQ and Tel Aviv Stock Exchange since August 2026. Further details can be found in the official English text below.

Source: Alpha Tau Medical (Official Press Release)

Read the original article